| Literature DB >> 22701481 |
Christiano D C Gati1, Márcia R Mortari, Elisabeth F Schwartz.
Abstract
Potassium channels are the most heterogeneous and widely distributed group of ion channels and play important functions in all cells, in both normal and pathological mechanisms, including learning and memory processes. Being fundamental for many diverse physiological processes, K(+)-channels are recognized as potential therapeutic targets in the treatment of several Central Nervous System (CNS) diseases, such as multiple sclerosis, Parkinson's and Alzheimer's diseases, schizophrenia, HIV-1-associated dementia, and epilepsy. Blockers of these channels are therefore potential candidates for the symptomatic treatment of these neuropathies, through their neurological effects. Venomous animals have evolved a wide set of toxins for prey capture and defense. These compounds, mainly peptides, act on various pharmacological targets, making them an innumerable source of ligands for answering experimental paradigms, as well as for therapeutic application. This paper provides an overview of CNS K(+)-channels involved in memory acquisition and storage and aims at evaluating the use of highly selective K(+)-channel blockers derived from arthropod venoms as potential therapeutic agents for CNS diseases involving learning and memory mechanisms.Entities:
Year: 2012 PMID: 22701481 PMCID: PMC3373146 DOI: 10.1155/2012/756358
Source DB: PubMed Journal: J Toxicol ISSN: 1687-8191
Figure 1Views of the Kv1.2-β 2 subunit complex. (a) Side view of the Kv1.2-β 2 structure with the extracellular solution above and the intracellular solution below. Four subunits of the channel are colored in yellow (T1 domain and voltage sensor) and green (pore). β subunit tetramer is colored in red. TM indicates the integral membrane component of the complex. (b) Stereoview of a single subunit of the channel and β subunit viewed from the side. Labels correspond to six transmembrane helices (S1 to S6). (c) View of the Kv1.2-β 2 structure from the extracellular side of the membrane. S1–S4 helices from each subunit form four surrounding voltage-sensing domains, S5-S6 regions (green) from the four subunits shape a single pore domain. Purple spheres are potassium ions. Images were generated using Protein Workshop Viewer 3.9 [15] and Protein Data Bank accession ID 2A79 [14].
Distribution of different types of K+ channels in hippocampus.
| Channels | Hippocampus | Employed technique | Ref. | ||
|---|---|---|---|---|---|
| CA1 | CA3 | DG | |||
| Kv1.1 | ++ | +++ | +++ | ISH, IMH, IMC, and CIMP in hippocampus or brain of rat, mouse, or gerbil. | [ |
| Kv1.2 | + | + | ++ | ||
| Kv1.3 | − | − | − | IMH in gerbil hippocampus. | [ |
| Kv1.4 | ++ | ++ | ++ | ISH, IMH, and IMC in hippocampus or brain of rat, mouse or gerbil. | [ |
| Kv1.5 | + | + | − | IMH or single-cell RT-PCR in gerbil or rat hippocampus. | [ |
| Kv1.6 | ++ | +++ | +++ | IMH in gerbil hippocampus. | [ |
| Kv2.1 | ++ | ++ | Single-cell RT-PCR in rat hippocampus. | [ | |
| Kv3.1 | ++ | +++ | +++ | Northern blot analysis and ISH in rat brain. | |
| Kv3.2 | +++ | ++ | − | [ | |
| Kv3.3 | + | + | ++ | ||
| Kv3.4 | − | − | ++ | ||
| Kv4.1 | + | + | ++ | ISH in rat brain. | [ |
| Kv4.2 | +++ | ++ | +++ | ISH or IMH in rat or mouse brain. | [ |
| Kv4.3 | + | ++ | +++ | ISH in rat brain. | [ |
| Kv7.2 | +++ | +++ | +++ | ISH and IMH in rat brain | |
| Kv7.3 | +++ | +++ | +++ | ||
| Kv10.1 | ++ | +++ | ++ | ISH, real time PCR, or IMH in rat brain. | [ |
| Kv10.2 | − | − | − | ISH and IMH in rat brain. | |
| Kv11.1 | ++ | − | − | ||
| Kv11.2 | − | − | − | [ | |
| Kv11.3 | +++ | − | − | ||
| Kv12.1 | + | − | + | ||
| Kv12.2 | ++ | − | ++ | ||
| KCa1.1 | +++ | +++ | +++ | ISH, WB analysis, IMH, IMF, IMC, or RLB in mouse or rat brain. | [ |
| KCa2.1 | ++ | +++ | ++ | ISH, IB analysis, IMH, or RLB in rat brain. | [ |
| KCa2.2 | +++ | +++ | + | ISH, IB analysis, IMH, or RLB in rat brain. | [ |
| KCa2.3 | + | ++ | + | ||
| K2P1.1 | − | ++ | ++ | ISH in rat and mouse brain. | |
| K2P2.1 | ++ | + | +++ | ISH, WB analysis, IMH, IMF, or IMC in rat or mouse brain. | [ |
| K2P3.1 | ++ | ++ | ++ | ISH in rat and mouse brain. | |
| K2P4.1 | ++ | +++ | + | [ | |
| K2P9.1 | ++ | ++ | +++ | ||
| K2P10.1 | − | ++ | + | ||
| Kir2.1 | + | + | +++ | ISH or IMH in mouse or rat brain. | [ |
| Kir2.2 | ++ | + | ++ | ISH in mouse or rat brain. | [ |
| Kir2.3 | ++ | + | +++ | ||
| Kir3.1 | +++ | ++ | +++ | ISH or IMH in rat brain. | [ |
| Kir3.2 | +++ | +++ | +++ | ISH or IMH in rat brain. | [ |
| Kir3.3 | +++ | +++ | +++ | ISH in rat brain | [ |
| Kir3.4 | + | ++ | + | WB analysis, IMH or ISH in rat or mouse brain. | [ |
| Kir6.2 | ++ | ++ | ++ | ISH, IMH, or IMF in rat or mouse brain. | [ |
The symbols indicate signal intensity as follows: − (not detected); + (weak); ++ (moderate); +++ (high); CA1, CA3, and DG (Dentate gyrus) are regions of hippocampal formation; Ref.: reference; RT-PCR means reverse transcription polymerase chain reaction; ISH is used for in situ hybridization; IMH for immunohistochemistry; IMC for immunocytochemistry; CIMP for coimmunoprecipitation; IMF for immunofluorescence; WB for western blot; IB for immune blot; RLB for radioligand binding.
K+ channels manipulations and their effects on experimental behavioral models for learning and memory.
| Channels | Technique | Effect on channel | Behavioral test | Result | Ref. |
|---|---|---|---|---|---|
| Kv, KCa, and Kir | icv of minoxidil, pinacidil, TEA, glibenclamine, gliquidone, and cromakalim. | TEA blocks Kv and KCa. Gliquidone and glibenclamide block Kir. Minoxidil, pinacidil and cromakalim open Kir | PAT in mice | Minoxidil, pinacidil and cromakalim: (−) | [ |
|
| |||||
| Kv1.1 | icv of antisense oligodeoxyribonucleotide to Kv1.1 mRNA. | Inhibition of channel expression | PAT in mice | (−) |
[ |
| MWM in rats | (−) | ||||
|
| |||||
| Kv12.2 | Kv12.2 (BEC1) knockout mice | Inhibition of channel expression | MWM | (+) | |
| Y-maze test | (+) | ||||
| WFT | (+) | ||||
| Kv12.2 OVER mice | Overexpression of channel in the forebrain | MWM | (−) | [ | |
| Y-maze test | (−) | ||||
| WFT | (−) | ||||
|
| |||||
| KCa2 | Systemic Infusion of EBIO or CyPPA. | EBIO activates SK channels. CyPPA activates KCa2.2 (SK2)/ KCa2.3 (SK3) subunits over KCa2.1 (SK1), and is more potent than EBIO. | ORT in mice | EBIO: (−) | |
| Contextual FCP in mice | EBIO: (0) | [ | |||
| Tone FCP in mice | EBIO: (0) | ||||
|
| |||||
| KCa1.1 | ih (CA1) of paxilline | Paxilline blocks the channel. | Trace eyeblink in rats | (−) | [ |
|
| |||||
| KCa2.2 | SK2-OVER mice | Overexpression of KCa2.2 (SK2) protein and KCa2.2 mRNA | MWM | (−) | |
| Contextual FCP | (−) | [ | |||
| Tone FCP | (−) | ||||
|
| |||||
| KCa2.2 | SK2-OVER mice | Overexpression of KCa2.2 (SK2) protein and KCa2.2 mRNA | Contextual FCP | (−) | [ |
|
| |||||
| KCa2.3 | Doxycycline-induced conditional SK3 channel deficient (T/T) mice | Inhibition of channel expression | PAT | (0) | |
| MWM | (0) | ||||
| ORT | (0) | ||||
| Y-maze test | (−) | [ | |||
| Five-trial inhibitory avoidance test | (−) | ||||
|
| |||||
| K2P10.1 | Infusion of siRNA in the EC. | Knock down K2p10.1 channels in the EC. | MWM in rats | (+) | [ |
|
| |||||
| Kir3.4 | Kir3.4 (GIRK4) knockout mice | Inhibition of channel expression | PAT | (0) | [ |
| MWM | (−) | ||||
|
| |||||
| Kir6.2 | ih (CA3) of diazoxide, or tolbutamide, or both. | Diazoxide opens the channel. Tolbutamide blocks the channel. | Contextual FCP in mice | Diazoxide: (−) Tolbutamide: (0) Both: (0) |
[ |
| Tone FCP in mice | Diazoxide, tolbutamide or both: (0) | ||||
| Kir6.2 knockout mice | Inhibition of channel expression | Contextual FCP | (−) | ||
| Tone FCP | (−) | ||||
| MWM | (0/−) | ||||
(−): impairment; (+): improved; (0): neutral; (0/−): slight impairment; (NT): not tested; Ref.: reference; icv: intracerebroventricular injection; ih: intra-hippocampal injection; EC: entorhinal cortex; OVER: overexpressing; EBIO: 1-ethyl-2-benzimidazolinone; CyPPA: Cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine; siRNA: small interfering RNA; PAT is used for passive-avoidance test; MWM for Morris water maze test; WFT for Water-finding task; ORT for object recognition task; FCP for fear-conditioning paradigm.
Assembled data on the effect of the bee and scorpion venom KTxs on the performance of animals in behavioral tests of learning and memory.
| Species | Toxin | KCN target | Behavioral test | Result | Ref. | |
|---|---|---|---|---|---|---|
| Scorpion |
| Kaliotoxin | Kv1.1 and Kv1.3 blocker | Olfactory discrimination task in rats | Improvement | [ |
|
| Iberiotoxin (IbTx) | KCa1.1 blocker | Passive avoidance test in chicks | Impaired retention | [ | |
|
| Charybdotoxin | Kv1.3 and KCa1.1 blocker | Passive avoidance test in mice | Improvement | [ | |
| Lei-Dab7 | KCa2.2 blocker | Radial arm maze in rat | No effect | [ | ||
|
| ||||||
| Bee |
| Apamin | KCa2.2 and KCa2.3 blocker | Bar-pressing response in appetitively motivated mice | Improvement | [ |
| Object recognition task in rats | Improvement | [ | ||||
| Habituation task in rats | Improvement | [ | ||||
| Passive avoidance test in rats or mice | No effect | [ | ||||
| Passive avoidance test in mice | Improvement | [ | ||||
| Morris water maze in mice | Improvement | [ | ||||
| Morris water maze in rats | No effect | [ | ||||
| Y-maze test in mice | No effect | [ | ||||
| Radial arm maze test in mice or rats | Improvement | [ | ||||
| Visual discrimination in rats | No effect | [ | ||||
| Olfactory discrimination task in rats | Improvement | [ | ||||
| Olfactory associative task in rats | Improvement | [ | ||||
| Tone fear-conditioning paradigm in mice | No effect | [ | ||||
| T-maze test in rats | Improvement | [ | ||||
| Passive avoidance task in chicks | Impaired retention | [ | ||||
Ref.: reference.